SynapDx's Series B - III Round

SynapDx raised a round of funding on March 27, 2013. Investors include The Kraft Group.

SynapDx is an early stage laboratory services company developing a blood based test to enable earlier detection of Autism Spectrum Disorders (ASDs). ASDs are characterized by impairment in language an…

Articles about SynapDx's Series B - III Round: